Revive Therapeutics Ltd. (TSX-V: RVV) (OTCQB: RVVTF) is focused on the research, development and commercialization of novel treatments for serious and unmet medical needs.   Revive’s drug discovery approach combines bioinformatics and drug development relationships with leading researchers and institutions.  Revive identifies and investigates potential therapies targeting the endocannabinoid system, such as cannabinoids, that may be repurposed for new indications, be delivered in a different way, or be developed as new chemical entities.